Andreessen Horowitz, established in 2009 by Marc Andreessen and Ben Horowitz, is a prominent venture capital firm based in Menlo Park, California. The company specializes in investing in software businesses, with a focus on sectors such as bio + healthcare, artificial intelligence, consumer, enterprise, fintech, and infrastructure. It typically invests in startups at various stages, from seed to late-stage, with a flexible investment range of $0.025 million to $50 million. The firm is known for its focus on disruptive technology and has raised multiple funds to support its investment strategy.
Operating Partner and Head of Crypto Startup Accelerator
Jay Rughani
Investing Partner
Katherine Rundell
Partner, Creators and Consumer GTM
Michael Sandwick
Partner, Consumer
Gil Shafir
Partner
Ian Shannon
Partner, Corporate Council
Laura Shores
Partner
Jeffrey Silverstein
Partner
Steven Sinofsky
Board Partner
Andrew Smith
Partner
Jack Soslow
Partner
Matt Spence
Partner
Nicole Stanners
Fundraise and IR Partner
Angela Strange
General Partner
Jeffrey Stump
Operating Partner
Jamie Sullivan
Partner
Satish Talluri
Partner
Kimberly Tan
Investment Partner
Carol Tang
Partner
Adela Tomsejova
Partner, Bio + Health
Dalton Turay
Partner
Gabriel Vasquez
Partner
Melissa Wasser
Partner, Capital Network
Margit Wennmachers
Operating Partner
Tyler Wilson
Partner
Daisy Wolf
Investing Partner
Carra Wu
Partner, Crypto Investments
Kevin Wu
Partner
Guy Wuollet
Partner
Shangda Xu
Partner
Zeya Yang
Partner
JJ Yu
Partner, Capital Network
Past deals in Healthcare
Thatch
Series B in 2025
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Juniper Behavioral Health
Series B in 2025
Juniper develops a behavioral health practice management software designed to streamline the logistical operations of clinics. The platform integrates various functions, including patient onboarding and billing, into a single cohesive system. It focuses on reducing manual tasks that clinicians typically encounter, thereby enhancing efficiency. Additionally, Juniper's software emphasizes compatibility with third-party applications, allowing for better automation and accountability across clinic operations. This holistic approach enables clinics to improve their reporting capabilities and manage their databases more effectively, ultimately supporting their growth and operational scalability.
Slingshot AI
Series A in 2025
Slingshot AI is an AI research company focused on enhancing global access to mental healthcare. With a mission to address the significant gap between the demand for mental health support and the availability of providers, which currently stands at 10,000:1, Slingshot AI develops advanced technology to assist individuals in improving their mental well-being and adaptability. The company specializes in creating large language models that grasp the intricacies of human psychology, enabling users to navigate daily challenges effectively. Based in New York City and London, Slingshot AI's multidisciplinary team of researchers, engineers, and mental health experts is committed to creating tools that empower individuals to overcome obstacles and foster better connections.
Hippocratic AI
Series B in 2025
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Infinitus Systems
Series C in 2024
Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.
Tennr
Series B in 2024
Tennr is a healthcare AI startup focused on optimizing operational efficiency in the healthcare sector by automating back-office tasks. The company has developed a workflow automation platform that tracks the lifecycle of patient referrals, allowing healthcare staff to reduce the time spent on manual workflows, information verification, and data entry. By replacing traditional faxing systems and enhancing communication processes, Tennr's technology facilitates timely care for patients and helps healthcare practices of all sizes achieve enterprise-quality automation.
Alchemy
Seed Round in 2024
Alchemy creates and implements clinical pharmacy programs and deploys technology products that use the pharmacy to expand access for patients, improve health outcomes, and increase the financial impact of a clinic's pharmacy program.
GC Therapeutics
Series A in 2024
GC Therapeutics specializes in synthetic biology to efficiently program patient-derived stem cells into various cell types. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, enabling streamlined manufacturing and improved quality of cell therapies. Their approach allows for the rapid differentiation of pluripotent stem cells, creating unique SuperCellsâ„¢ customized for specific medical conditions. The foundational technology was developed in Professor George Church's lab at Harvard Medical School, and the team at GC Therapeutics comprises dedicated biologists and tissue engineers focused on translating this innovative method into practical therapies for patients.
Thatch
Series A in 2024
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Levels
Series A in 2024
Levels is a health and wellness company that focuses on metabolic fitness through a platform that tracks blood glucose levels in real-time. Founded in 2019, the company offers a wearable device that provides users with immediate feedback on their unique metabolism. This data enables individuals to understand how their bodies respond to various dietary and lifestyle choices, allowing them to optimize their nutrition and exercise routines to meet personal health goals. Operating as a remote-first organization, Levels aims to empower users to take control of their metabolic health.
Headway
Series D in 2024
Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.
Q Bio
Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in fields such as applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Formation Bio
Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Pomelo Care
Series B in 2024
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.
Talkiatry
Series C in 2024
Talkiatry is a provider of virtual psychiatry services that connects patients with a team of over 300 licensed psychiatrists. The company focuses on making high-quality mental health care accessible and convenient, specializing in the treatment of conditions such as anxiety, depression, ADHD, and substance use disorders. Utilizing an interactive process with evidence-based assessments, Talkiatry offers preliminary diagnoses and severity evaluations, facilitating easier access to in-network healthcare. Through personalized treatment plans, including medication management when necessary, Talkiatry aims to improve the overall mental health treatment experience for patients.
Santa Ana Bio
Series B in 2024
Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.
Valar Labs
Series A in 2024
Valar Labs is a healthcare technology company founded in 2021 by Anirudh Joshi, Viswesh Krishna, Pranav Rajpurkar, and Damir Vrabac. The company leverages artificial intelligence to enhance cancer treatment by analyzing imaging data typically used in routine clinical care. Valar Labs provides a software platform that offers interpretable and actionable insights, assisting oncologists in making informed treatment decisions tailored to each patient's unique characteristics. Through this approach, Valar Labs aims to improve patient outcomes and support doctors in delivering optimal care for individuals battling cancer.
xAI
Series B in 2024
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.
Tennr
Series A in 2024
Tennr is a healthcare AI startup focused on optimizing operational efficiency in the healthcare sector by automating back-office tasks. The company has developed a workflow automation platform that tracks the lifecycle of patient referrals, allowing healthcare staff to reduce the time spent on manual workflows, information verification, and data entry. By replacing traditional faxing systems and enhancing communication processes, Tennr's technology facilitates timely care for patients and helps healthcare practices of all sizes achieve enterprise-quality automation.
Hippocratic AI
Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Milu Health
Seed Round in 2024
Milu Health is a healthcare platform focused on simplifying and reducing the costs of healthcare for employees. The company utilizes electronic health records, claims, and pricing data to uncover opportunities for cost savings in the healthcare system. By providing price transparency, Milu Health helps users identify high-quality and reasonably priced doctors and hospitals for common procedures and surgeries. This approach allows patients to find ways to save on their doctor visits, medical bills, procedures, and prescription drugs, ultimately aiming to make healthcare more accessible and affordable.
Ambience Healthcare
Series B in 2024
Ambience Healthcare specializes in developing artificial intelligence-powered solutions aimed at enhancing the efficiency of healthcare providers. Their flagship product is a medical scribe that utilizes advanced speech recognition technology to capture clinician-patient conversations in real-time, transforming them into comprehensive notes that seamlessly integrate into electronic medical record systems. This innovative approach significantly reduces documentation time, with healthcare systems reporting an average decrease of 78%. By automating the documentation process, Ambience Healthcare aims to alleviate clinician burnout, improve coding accuracy, and ensure high-quality patient care. The company's technology not only allows clinicians to complete their charts swiftly but also enables customization to align with individual providers' styles and preferences, ultimately contributing to a more efficient healthcare environment.
Turquoise Health
Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Talofa
Seed Round in 2024
Talofa is building games that make players mentally and physically healthier. Their flagship game on the platform, Run Legends, got over 300,000 downloads in the first 3 months and was featured as one of the "Best New Games" by Apple and Google Play Stores. Talofa’s team has been built up with game veterans from EA, 2K, and Riot Games and the CEO, Jenny Xu, has created mobile games with over 10M downloads.
Waymark
Venture Round in 2023
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Mana.bio
Seed Round in 2023
Mana.bio is an AI-based drug delivery startup that specializes in gene therapy, focusing on both DNA and RNA-based therapeutics as well as vaccines. The company utilizes advanced technology that combines machine learning with nanotechnology to enhance the development of lipid nanoparticle systems, which are crucial for oligonucleotide therapies. By identifying optimal formulations for these delivery systems, Mana.bio aims to improve drug delivery services in the healthcare industry, thereby facilitating more effective therapeutic solutions.
Headway
Series C in 2023
Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.
BetterLeap
Seed Round in 2023
Betterleap is an innovative platform designed to assist healthcare professionals in advancing their careers. By leveraging artificial intelligence, it automates the job search process and provides tailored career opportunities that align with users' skills and aspirations. The platform offers curated job listings and personalized recommendations, making it easier for healthcare workers, whether seasoned practitioners or newcomers, to find roles that resonate with their values. Betterleap aims to empower its users by streamlining their job search experience through an easy-to-navigate mobile app, ultimately enhancing their chances of securing meaningful career positions in patient care.
Bold
Series A in 2023
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.
Inceptive
Series A in 2023
Inceptive specializes in the design of RNA molecules through the integration of large-scale deep learning and high-throughput experiments. The company has developed a platform for biological software that facilitates the creation of synthetic molecules capable of performing complex biological functions. By focusing on the rational design of innovative medicines and biotechnologies, Inceptive aims to provide advancements in healthcare and biotechnology that were previously beyond reach.
Pomelo Care
Series A in 2023
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.
Caresync.website
Series A in 2023
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.
Hippocratic AI
Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Memora Health
Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Zus Health
Series A in 2023
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Thatch
Pre Seed Round in 2023
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Thatch
Seed Round in 2023
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Levels
Series A in 2023
Levels is a health and wellness company that focuses on metabolic fitness through a platform that tracks blood glucose levels in real-time. Founded in 2019, the company offers a wearable device that provides users with immediate feedback on their unique metabolism. This data enables individuals to understand how their bodies respond to various dietary and lifestyle choices, allowing them to optimize their nutrition and exercise routines to meet personal health goals. Operating as a remote-first organization, Levels aims to empower users to take control of their metabolic health.
Pearl Health
Venture Round in 2022
Pearl Health is a technology and services company focused on enhancing primary care delivery and improving patient outcomes. Founded in 2020, it partners with thousands of primary care providers across 44 states to facilitate quality healthcare while rewarding providers for maintaining patient health. The company's platform offers a range of tools, including fixed per-member payments, clinical insights through analytics, and assistance with direct contracting programs. These resources enable physicians to concentrate on patient care while also reducing overall healthcare costs and optimizing performance within value-based care models for Traditional Medicare and Medicare Advantage. Pearl Health's team consists of experienced professionals from various fields, including medicine, public health, and technology, all dedicated to addressing significant challenges within the healthcare system.
Firefly Health
Venture Round in 2022
Firefly Health, Inc. is a Massachusetts-based company that develops an artificial intelligence-driven platform to connect patients with healthcare professionals. Founded in 2016, it focuses on providing primary healthcare services that emphasize accessibility and quality. The platform allows users to navigate their health while offering care for common conditions such as back pain, stomach flu, and women's health issues. Firefly Health utilizes a virtual-first approach, enabling patients to access live video appointments with primary care physicians without membership fees. This model facilitates continuous and intelligent care, empowering patients to make informed health choices and allowing clinicians to deliver consistent and proactive support.
Rezo Therapeutics
Series A in 2022
Rezo Therapeutics is a biotechnology company that focuses on developing precision therapeutics by mapping disease networks. Utilizing its proprietary Sequence to Systems to Drugs (SSD) platform, Rezo integrates various technologies, including proteomics, genetics, structural biology, chemistry, and bioinformatics, to create comprehensive molecular maps of diseases. This innovative approach enhances the identification of novel targets and therapies, particularly in oncology, where Rezo initially concentrates its efforts. The company aims to expand its therapeutic focus through collaborations and partnerships, positioning itself at the forefront of advancing treatment options across multiple disease areas.
Revero
Seed Round in 2022
Revero is an online clinic focused on treating chronic conditions through a root-cause approach. Founded in 2019 and based in San Francisco, California, the company offers personalized treatments for autoimmune and metabolic disorders using nutrition therapy and remote medical care. Revero's platform combines nutritional therapy and clinical expertise with machine learning and digital tools, allowing patients to monitor their health progress and receive tailored feedback. The primary objectives of Revero include helping patients lower blood sugar, improve metabolic health, reduce inflammation, and restore gut health.
Cipher Skin
Venture Round in 2022
Cipher Skin Inc. is a technology company based in Denver, Colorado, founded in 2014. The company specializes in developing a unique mesh technology that allows sensors to contour around the human body, enabling the capture of multiple simultaneous measurements. This technology provides vital data regarding three-dimensional movement and biosignals such as heart rate and oxygen saturation. By translating this data into actionable insights, Cipher Skin aims to create a comprehensive data platform that enhances the monitoring and analysis of physical performance. Its innovative approach supports physical therapists and trainers in designing safe and effective rehabilitation and training programs by accurately measuring complex motions, particularly in the upper limbs.
Incredible Health
Series B in 2022
Incredible Health, Inc. operates a technology-driven platform that connects healthcare providers with nursing professionals to address staffing challenges. Founded in 2015 and based in San Francisco, the company offers a subscription-based job portal that facilitates the recruitment process for medical candidates. This platform allows users, including fresh graduates, unemployed medical staff, and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Utilizing AI technology, Incredible Health custom matches healthcare organizations with qualified nurses for hard-to-fill positions, aiming to enhance the hiring experience and improve the lives of healthcare professionals.
Vicinitas Therapeutics
Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
BigHat Biosciences
Series B in 2022
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.
Cartography Biosciences
Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.
Tomorrow Health
Series B in 2022
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.
Ultima Genomics
Venture Round in 2022
Ultima Genomics, founded in 2016 and based in Newark, California, specializes in genome-scale sequencing technology aimed at providing analytical services to enterprises. The company employs an innovative approach using an open substrate that creates a large, low-cost reaction surface, allowing for billions of reads without the need for expensive flow cells or complex fluidics. By integrating specialized sequencing hardware with machine learning, Ultima Genomics ensures reproducible and accurate results, enabling clients to obtain genomic reports rapidly and efficiently. This technology not only enhances the scale of genomic information but also significantly reduces the costs associated with sequencing, thereby facilitating advancements in biology and improvements in human health.
Locale
Seed Round in 2022
We create organic high-protein meals with high standards, backed by leading longevity research. Our standards: - 40-60g protein per meal - Nutrient-dense meat (grass-fed, pasture-raised, wild-caught) - No seed oils (cooked in extra virgin olive oil) - 8g+ fiber per meal - Organic, pesticide-free produce - No processed ingredients. No refined sugars - Microplastic-free, reusable glass jars - High in Anti-inflammatories, and Omega-3s Since starting in 2020, we’ve delivered 100K+ orders and are backed by a16z, Y-Combinator, Goodwater, Decent Capital, and other top investors.
Turquoise Health
Series A in 2022
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Octant Bio
Series B in 2022
Octant Bio is a biotechnology company focused on developing synthetic technology aimed at enhancing health and treating diseases. The company employs a platform that integrates synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. This advanced technology allows scientists to utilize machine learning techniques to engineer small molecules capable of interacting with multiple receptors, thereby creating new possibilities for the treatment of complex diseases.
Season Health
Series A in 2022
Season is a platform that offers personalized nutrition planning for consumers. It integrates technology with advice from users' registered dietitians to help them get more out of their nutrition and make the most out of mealtime every day. The platform recommends what to eat for breakfast, lunch, and dinner based on nutritional needs, food preferences, and budget.
Memora Health
Venture Round in 2022
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Topography Health
Series A in 2022
Topography Health is a clinical trials platform designed to facilitate private practice physicians' participation in medical research. The company aids medical practices in understanding their patient demographics and recommends suitable studies that are likely to be effective and well-received. Additionally, Topography assists in patient recruitment and the hiring and management of research staff. By enabling local clinical trials, Topography Health provides patients with various health conditions access to personalized clinical trial opportunities, ultimately advancing medical research and overcoming barriers that physicians face in entering this field.
Nitra
Seed Round in 2022
Nitra is a financial technology company focused on enhancing the healthcare industry through efficient and transparent solutions. The company offers a platform that provides machine learning-powered financial software, including credit cards, loans, accounts, payments, and expense management tailored for medical professionals. Nitra's tools help healthcare providers streamline their spending and manage payments in one centralized location, offering a clear overview of daily expenses. The Nitra Visa Business Card rewards users with benefits for every transaction and provides access to discounts through a network of partners. By simplifying accounting and receipt reconciliation, Nitra aims to support healthcare providers in balancing patient care with efficient practice management, delivering modern technology and dedicated support to the sector.
Waymark
Series A in 2022
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Ribbon Health
Series B in 2021
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the quality and cost of care. The platform includes features such as provider directories, referral management, care navigation, and insurance enrollment. Ribbon Health serves various clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. The company was incorporated in 2016 and is headquartered in New York, New York. Originally named HealthWiz, Inc., it rebranded to Ribbon Health, Inc. in March 2018.
Patina Health
Series A in 2021
Patina is a healthcare provider focused on enhancing the aging experience for older adults and their families. The company has developed a care model that prioritizes the unique needs and values of this demographic. By offering personalized and on-demand services, Patina aims to create a healthcare experience that is both human-centered and supportive. This approach allows families to actively participate in the care of their loved ones, ensuring that older adults receive the attention and respect they deserve as they navigate the challenges of aging. Patina's mission is to empower individuals to live their best lives and maintain their dignity as they age.
Sprinter Health
Series A in 2021
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.
Pearl Health
Series A in 2021
Pearl Health is a technology and services company focused on enhancing primary care delivery and improving patient outcomes. Founded in 2020, it partners with thousands of primary care providers across 44 states to facilitate quality healthcare while rewarding providers for maintaining patient health. The company's platform offers a range of tools, including fixed per-member payments, clinical insights through analytics, and assistance with direct contracting programs. These resources enable physicians to concentrate on patient care while also reducing overall healthcare costs and optimizing performance within value-based care models for Traditional Medicare and Medicare Advantage. Pearl Health's team consists of experienced professionals from various fields, including medicine, public health, and technology, all dedicated to addressing significant challenges within the healthcare system.
ROME Therapeutics
Series B in 2021
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.
Pomelo Care
Seed Round in 2021
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.
Turquoise Health
Seed Round in 2021
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Bayesian Health
Venture Round in 2021
Bayesian Health Inc. is a digital health company based in New York, established in 2016. It specializes in an AI-driven platform that enhances patient monitoring by assessing illness severity and detecting changes in acuity. This technology integrates with hospital electronic medical records (EMR), allowing clinical staff and hospital leadership to access real-time data and insights. The platform provides actionable early detection alerts and supports decision-making in complex clinical environments, ultimately optimizing patient care throughout their hospital stay. By leveraging existing investments in EMR systems, Bayesian Health enables healthcare providers to make informed, data-driven decisions that improve safety and efficiency in patient management.
Zus Health
Series A in 2021
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Memora Health
Venture Round in 2021
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Headway
Series B in 2021
Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.
Tomorrow Health
Series A in 2021
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.
Firefly Health
Series B in 2021
Firefly Health, Inc. is a Massachusetts-based company that develops an artificial intelligence-driven platform to connect patients with healthcare professionals. Founded in 2016, it focuses on providing primary healthcare services that emphasize accessibility and quality. The platform allows users to navigate their health while offering care for common conditions such as back pain, stomach flu, and women's health issues. Firefly Health utilizes a virtual-first approach, enabling patients to access live video appointments with primary care physicians without membership fees. This model facilitates continuous and intelligent care, empowering patients to make informed health choices and allowing clinicians to deliver consistent and proactive support.
AKASA
Series B in 2021
AKASA is a leading developer of AI-powered automation solutions tailored for the healthcare revenue cycle. The company focuses on enhancing complex workflows, which allows healthcare providers to improve revenue outcomes and operational efficiency. By automating tasks such as prior authorization and claims processing, AKASA addresses time-consuming challenges that were previously difficult to resolve at scale. Their technology leverages advanced AI and machine learning to streamline revenue cycle management, resulting in significant performance improvements. Clients have reported a 13% reduction in accounts receivable days, an 86% increase in efficiency, and the saving of over 300 hours of staff time each month. With a commitment to data security and measurable results, AKASA has garnered substantial investment to advance its mission of simplifying the financial aspects of healthcare.
Komodo Health
Series E in 2021
Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.
Cedar
Series D in 2021
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and headquartered in New York, United States.
BigHat Biosciences
Series A in 2021
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.
Bold
Seed Round in 2021
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.
EQRx
Series B in 2021
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.
Levels
Seed Round in 2020
Levels is a health and wellness company that focuses on metabolic fitness through a platform that tracks blood glucose levels in real-time. Founded in 2019, the company offers a wearable device that provides users with immediate feedback on their unique metabolism. This data enables individuals to understand how their bodies respond to various dietary and lifestyle choices, allowing them to optimize their nutrition and exercise routines to meet personal health goals. Operating as a remote-first organization, Levels aims to empower users to take control of their metabolic health.
FidoCure
Series A in 2020
FidoCure is dedicated to advancing canine cancer care through the use of AI-driven precision medicine. The company has established the largest proprietary learning database for canine cancer by utilizing data from naturally occurring cases and next-generation sequencing. FidoCure focuses on providing personalized medicine services, which go beyond traditional chemotherapy and radiation. By collecting tissue samples for DNA sequencing, the company generates detailed reports that identify genetic mutations influencing treatment options. This approach enables veterinarians and pet owners to implement targeted therapies that specifically address cancer cells, ultimately improving the quality of life for dogs facing cancer. Furthermore, FidoCure bridges the gap between human and veterinary oncology, fostering comparative oncology and creating innovative drug development opportunities that benefit both pets and humans.
Cedar
Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and headquartered in New York, United States.
AKASA
Series A in 2020
AKASA is a leading developer of AI-powered automation solutions tailored for the healthcare revenue cycle. The company focuses on enhancing complex workflows, which allows healthcare providers to improve revenue outcomes and operational efficiency. By automating tasks such as prior authorization and claims processing, AKASA addresses time-consuming challenges that were previously difficult to resolve at scale. Their technology leverages advanced AI and machine learning to streamline revenue cycle management, resulting in significant performance improvements. Clients have reported a 13% reduction in accounts receivable days, an 86% increase in efficiency, and the saving of over 300 hours of staff time each month. With a commitment to data security and measurable results, AKASA has garnered substantial investment to advance its mission of simplifying the financial aspects of healthcare.
PatientPing
Series C in 2020
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.
Octant Bio
Series A in 2020
Octant Bio is a biotechnology company focused on developing synthetic technology aimed at enhancing health and treating diseases. The company employs a platform that integrates synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. This advanced technology allows scientists to utilize machine learning techniques to engineer small molecules capable of interacting with multiple receptors, thereby creating new possibilities for the treatment of complex diseases.
Topography Health
Venture Round in 2020
Topography Health is a clinical trials platform designed to facilitate private practice physicians' participation in medical research. The company aids medical practices in understanding their patient demographics and recommends suitable studies that are likely to be effective and well-received. Additionally, Topography assists in patient recruitment and the hiring and management of research staff. By enabling local clinical trials, Topography Health provides patients with various health conditions access to personalized clinical trial opportunities, ultimately advancing medical research and overcoming barriers that physicians face in entering this field.
Tomorrow Health
Seed Round in 2020
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.
Devoted
Series C in 2020
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.
Ribbon Health
Series A in 2020
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the quality and cost of care. The platform includes features such as provider directories, referral management, care navigation, and insurance enrollment. Ribbon Health serves various clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. The company was incorporated in 2016 and is headquartered in New York, New York. Originally named HealthWiz, Inc., it rebranded to Ribbon Health, Inc. in March 2018.
Q Bio
Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in fields such as applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Buck Stash
Series A in 2020
Buck Stash is a venture capital firm that specializes in seed, early, mid, and late stage investments. It prefers to invest in the social media business and technology sector, with a focus on software, back-end infrastructure, Internet infrastructure, cloud computing, enterprise software and services, consumer, business Internet, mobile Internet, consumer Internet, cloud computing, data-storage, social network browsers data-storage, consumer electronics, networking functions, software related biology, biotech, and medicine companies at the intersection of computer science and medicine
EQRx
Series A in 2020
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.
Komodo Health
Series C in 2020
Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.
Tmunity
Series B in 2019
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune conditions. Founded in 2015, Tmunity specializes in creating engineered T cells, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg), utilizing proprietary technologies to activate, expand, and genetically modify T cells sourced from peripheral blood, cord blood, and tumors. The company aims to harness the potential of T cells to provide personalized next-generation treatments and is advancing its clinical programs in various disease areas. Tmunity's team is comprised of experts in T-cell biology, regulatory affairs, and clinical development, with a strong track record in executing successful cell and gene therapy trials. Additionally, Tmunity has established a robust manufacturing platform that supports multi-center clinical studies across diverse therapeutic indications.
Incredible Health
Series A in 2019
Incredible Health, Inc. operates a technology-driven platform that connects healthcare providers with nursing professionals to address staffing challenges. Founded in 2015 and based in San Francisco, the company offers a subscription-based job portal that facilitates the recruitment process for medical candidates. This platform allows users, including fresh graduates, unemployed medical staff, and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Utilizing AI technology, Incredible Health custom matches healthcare organizations with qualified nurses for hard-to-fill positions, aiming to enhance the hiring experience and improve the lives of healthcare professionals.
Omada
Series D in 2019
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Health IQ
Series D in 2019
Health IQ is a health insurance marketplace focused on promoting health literacy and rewarding health-conscious individuals with lower insurance rates. The company aims to recognize and celebrate those committed to maintaining their health, rather than penalizing those who do not. By leveraging a platform that assesses users' health status, knowledge, and active lifestyles, Health IQ provides tailored insurance solutions, including life and Medicare insurance. This approach not only encourages healthier living but also offers affordable rates based on individual lifestyles, ultimately contributing to the broader goal of enhancing health literacy worldwide.
FidoCure
Seed Round in 2019
FidoCure is dedicated to advancing canine cancer care through the use of AI-driven precision medicine. The company has established the largest proprietary learning database for canine cancer by utilizing data from naturally occurring cases and next-generation sequencing. FidoCure focuses on providing personalized medicine services, which go beyond traditional chemotherapy and radiation. By collecting tissue samples for DNA sequencing, the company generates detailed reports that identify genetic mutations influencing treatment options. This approach enables veterinarians and pet owners to implement targeted therapies that specifically address cancer cells, ultimately improving the quality of life for dogs facing cancer. Furthermore, FidoCure bridges the gap between human and veterinary oncology, fostering comparative oncology and creating innovative drug development opportunities that benefit both pets and humans.
Ciitizen
Series A in 2019
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
AKASA
Seed Round in 2019
AKASA is a leading developer of AI-powered automation solutions tailored for the healthcare revenue cycle. The company focuses on enhancing complex workflows, which allows healthcare providers to improve revenue outcomes and operational efficiency. By automating tasks such as prior authorization and claims processing, AKASA addresses time-consuming challenges that were previously difficult to resolve at scale. Their technology leverages advanced AI and machine learning to streamline revenue cycle management, resulting in significant performance improvements. Clients have reported a 13% reduction in accounts receivable days, an 86% increase in efficiency, and the saving of over 300 hours of staff time each month. With a commitment to data security and measurable results, AKASA has garnered substantial investment to advance its mission of simplifying the financial aspects of healthcare.
Ciitizen
Venture Round in 2018
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
insitro
Series A in 2018
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.
Accolade
Series F in 2018
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.